Information Library
Results for: Demonstrating Value
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Reinventing Biopharma
White Paper — February 1, 2012
The biopharmaceutical industry today is facing a multifaceted “value challenge.” -
The Power of Observation
Hear from the Experts — January 26, 2012
As the name implies, in observational studies one 'observes.' The choice of therapy is determined by the patient and her physician rather than protocol, and, -
Making Observational Studies Count
Hear from the Experts — January 26, 2012
There is substantial interest in using observational epidemiologic research in combination with randomized clinical trials (RCTs) and meta-analyses to support decisionmaking by regulators, payers, and -
Patient Registries for Understanding the Natural History of Diseases
Hear from the Experts — January 26, 2012
Understanding the natural history of a disease - its characteristics. management. and outcomes with or without treatment - is critical for developing new therapies. identifying -
Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk-Benefit Assessment
Hear from the Experts — November 10, 2011
Concerns about safety, value, and outcomes are driving demand for more robust evidence about biopharmaceuticals and other medical interventions. -
Methods Matter
White Paper — July 18, 2011
As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs. -
The Effect of Comparative Effectiveness Research on Drug Development Innovation
Hear from the Experts — May 20, 2011
In healthcare the drug development process is in dire need of transformation, and Comparative Effectiveness Research (CER) is helping to fundamentally change drug development by forcing biopharmaceutical manufacturers to view drug innovation from a holistic, 360 degree perspective. -
Vaccine Insights
Presentation — April 19, 2011
Quintiles’ Jason Baumgartner, Life Sciences Consulting Director, presented on “Understanding Socio-Economic Drivers to Increase Vaccination Coverage” at the World Vaccine Congress 2011 -
New Healthcare Architecture to Maximize Vaccine Coverage Rates
Hear from the Experts — April 19, 2011
Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine. -
Podcast: Observational Research through Online Patient Communities
Hear from the Experts — March 26, 2011
Elisa Cascade, Vice President of MediGuard, discusess how observational research can be conducted with the rich real-world outcomes data available through online patient communities.
